About: Seproxetine

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Seproxetine, also known as (S)-norfluoxetine, is a selective serotonin reuptake inhibitor (SSRI). It is the S enantiomer of norfluoxetine, the main active metabolite of the widely used antidepressant fluoxetine; but little is known about its pharmacological actions. Seproxetine was being investigated by Eli Lilly and Company as an antidepressant; however, cardiac side effects were discovered and development was discontinued.

thumbnail
Property Value
dbo:abstract
  • Seproxetine, also known as (S)-norfluoxetine, is a selective serotonin reuptake inhibitor (SSRI). It is the S enantiomer of norfluoxetine, the main active metabolite of the widely used antidepressant fluoxetine; but little is known about its pharmacological actions. Seproxetine was being investigated by Eli Lilly and Company as an antidepressant; however, cardiac side effects were discovered and development was discontinued. (en)
  • セプロキセチン(Seproxetine)または(S)-ノルフルオキセチン((S)-norfluoxetine)は、選択的セロトニン再取り込み阻害薬(SSRI)である。広く用いられる抗うつ薬であるフルオキセチンの最も重要なであるが、薬理作用についてはほとんど分かっていない。セプロキセチンは、イーライリリー・アンド・カンパニーによって抗うつ薬として開発したが、心臓への副作用が報告され、開発は中止された。 (ja)
dbo:casNumber
  • 126924-38-7
dbo:drugbank
  • DB06731
dbo:fdaUniiCode
  • 25CO3X0R31
dbo:pubchem
  • 4541
dbo:thumbnail
dbo:wikiPageID
  • 14173544 (xsd:integer)
dbo:wikiPageLength
  • 1818 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1074765657 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:c
  • 16 (xsd:integer)
dbp:casNumber
  • 126924 (xsd:integer)
dbp:chemspiderid
  • 4382 (xsd:integer)
dbp:drugbank
  • DB06731 (en)
dbp:eliminationHalfLife
  • -1382400.0
dbp:f
  • 3 (xsd:integer)
dbp:h
  • 16 (xsd:integer)
dbp:iupacName
  • -3 (xsd:integer)
dbp:iupharLigand
  • 208 (xsd:integer)
dbp:legalStatus
  • Uncontrolled (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 1 (xsd:integer)
dbp:pubchem
  • 4541 (xsd:integer)
dbp:unii
  • 25 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Seproxetine, also known as (S)-norfluoxetine, is a selective serotonin reuptake inhibitor (SSRI). It is the S enantiomer of norfluoxetine, the main active metabolite of the widely used antidepressant fluoxetine; but little is known about its pharmacological actions. Seproxetine was being investigated by Eli Lilly and Company as an antidepressant; however, cardiac side effects were discovered and development was discontinued. (en)
  • セプロキセチン(Seproxetine)または(S)-ノルフルオキセチン((S)-norfluoxetine)は、選択的セロトニン再取り込み阻害薬(SSRI)である。広く用いられる抗うつ薬であるフルオキセチンの最も重要なであるが、薬理作用についてはほとんど分かっていない。セプロキセチンは、イーライリリー・アンド・カンパニーによって抗うつ薬として開発したが、心臓への副作用が報告され、開発は中止された。 (ja)
rdfs:label
  • セプロキセチン (ja)
  • Seproxetine (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License